We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
-1.05%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.21B
AUM Growth
-$63.8M
(-5%)
Cap. Flow
-$38.3M
Cap. Flow
% of AUM
-3.17%
Top 10 Holdings %
Top 10 Hldgs %
51.8%
Holding
34
New
3
Increased
6
Reduced
12
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WMGI
Wright Medical Group Inc
WMGI
|
+$53.6M |
| 2 |
Zimmer Biomet
ZBH
|
+$42.1M |
| 3 |
Etsy
ETSY
|
+$37.8M |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
+$24.6M |
| 5 |
Atara Biotherapeutics
ATRA
|
+$14M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$38.6M |
| 2 |
MDCO
Medicines Co
MDCO
|
+$36.2M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
+$21.8M |
| 4 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
+$21.6M |
| 5 |
Rocket Pharmaceuticals
RCKT
|
+$18.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.16% |
| 2 | Consumer Discretionary | 17.55% |
| 3 | Technology | 14.39% |
| 4 | Communication Services | 7.67% |
| 5 | Consumer Staples | 5.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PVG
26
DELISTED
PRETIUM RESOURCES INC.
PVG
| $19M | 1.57% |
1,651,328
| – | – |
|
27
DexCom
DXCM
$32.3B
| $14.3M | 1.18% |
382,704
-76,724
| -17% | -$2.98M |
|
28
TG Therapeutics
TGTX
$7.95B
| $13.1M | 1.08% |
2,334,196
-1,080,472
| -32% | -$7.53M |
|
29
Teva Pharmaceuticals
TEVA
$40.7B
| $10.3M | 0.85% |
1,500,000
| – | – |
|
|
GDEN
30
DELISTED
Golden Entertainment
GDEN
| $6.87M | 0.57% |
516,742
-305,745
| -37% | -$4.26M |
|
31
Cyclerion Therapeutics
CYCN
$15.1M
| – | – |
-51,632
| Closed | -$11.8M |
|
|
32
Nektar Therapeutics
NKTR
$2.38B
| – | – |
-72,240
| Closed | -$38.6M |
|
|
33
Rocket Pharmaceuticals
RCKT
$339M
| – | – |
-1,247,366
| Closed | -$18.7M |
|
34
Wave Life Sciences
WVE
$1.09B
| – | – |
-653,141
| Closed | -$17M |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q3 2019 Portfolio in Review
As of Q3 2019, Bridger Management held 34 positions worth $1.21B, down 5% from $1.27B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Bridger Management withdrew a net $38.3M in Q3 2019, closing 4 positions and reducing 12 holdings. Its most notable exit was Nektar Therapeutics, an estimated $38.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Bridger Management opened a new position in Wright Medical Group Inc worth $46.5M.
- Bridger Management's largest Q3 2019 buy was Wright Medical Group Inc: 2,251,809 shares worth $46.5M.
- Bridger Management added most to Zimmer Biomet in Q3 2019, an estimated $42.1M increase.
- Bridger Management's biggest Q3 2019 reduction was Medicines Co, cutting an estimated $36.2M.
- Bridger Management fully exited Nektar Therapeutics in Q3 2019, selling an estimated $38.6M.
- Bridger Management's ten largest holdings make up 52% of its $1.21B portfolio in Q3 2019.
- Bridger Management opened 3 new positions and closed 4 in Q3 2019.
- Bridger Management's portfolio value fell 5% quarter-over-quarter to $1.21B.
Based on Bridger Management's 13F filing for Q3 2019, filed 14 Nov 2019.